Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Neurobiol Dis ; 77: 238-45, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25796567

RESUMEN

Endocannabinoids, including 2-arachidonoylglycerol (2-AG), activate presynaptic cannabinoid type 1 receptors (CB1R) on inhibitory and excitatory neurons, resulting in a decreased release of neurotransmitters. The event-specific activation of the endocannabinoid system by inhibition of the endocannabinoid degrading enzymes may offer a promising strategy to selectively activate CB1Rs at the site of excessive neuronal activation with the overall goal to prevent the development epilepsy. The aim of this study was to investigate the impact of monoacylglycerol lipase (MAGL) inhibition on the development and progression of epileptic seizures in the kindling model of temporal lobe epilepsy. Therefore, we selectively blocked MAGL by JZL184 (8mg/kg, i.p.) in mice to analyze the effects of increased 2-AG levels on kindling acquisition and to exclude an anticonvulsive potential. Our results showed that JZL184 treatment significantly delayed the development of generalized seizures (p=0.0066) and decreased seizure (p<0.0001) and afterdischarge duration (p<0.001) in the kindling model of temporal lobe epilepsy, but caused only modest effects in fully kindled mice. Moreover, we proved that JZL184 treatment had no effects in conditional CB1R knockout mice lacking expression of the receptor in principle neurons of the forebrain. In conclusion, the data demonstrate that indirect CB1R agonism delays the development of generalized epileptic seizures but has no relevant acute anticonvulsive effects. Furthermore, we confirmed that the effects of JZL184 on kindling progression are CB1R mediated. Thus, the data indicate that the endocannabinoid 2-AG might be a promising target for an anti-epileptogenic approach.


Asunto(s)
Benzodioxoles/uso terapéutico , Inhibidores Enzimáticos/uso terapéutico , Excitación Neurológica/genética , Monoacilglicerol Lipasas/metabolismo , Piperidinas/uso terapéutico , Receptor Cannabinoide CB1/metabolismo , Amígdala del Cerebelo/metabolismo , Análisis de Varianza , Animales , Modelos Animales de Enfermedad , Epilepsia/etiología , Regulación de la Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/genética , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Masculino , Ratones , Ratones Transgénicos , Tiempo de Reacción/efectos de los fármacos , Receptor Cannabinoide CB1/genética
2.
Neurobiol Dis ; 73: 334-47, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25123336

RESUMEN

The endocannabinoid system serves as a retrograde negative feedback mechanism. It is thought to control neuronal activity in an epileptic neuronal network. The purpose of this study was to evaluate the impact of the endocannabinoid and endovanilloid systems on both epileptogenesis and ictogenesis. Therefore, we modulated the endocannabinoid and endovanilloid systems genetically and pharmacologically, and analyzed the subsequent impact on seizure progression in the kindling model of temporal lobe epilepsy in mice. In addition, the impact of seizures on associated cellular alterations was evaluated. Our principal results revealed that the endocannabinoid system affects seizure and afterdischarge duration dependent on the neuronal subpopulation being modulated. Genetic deletion of CB1-receptors (CB1Rs) from principal neurons of the forebrain and pharmacological antagonism with rimonabant (5 mg/kg) caused longer seizure duration. Deletion of CB1R from GABAergic forebrain neurons resulted in the opposite effect. Along with these findings, the CB1R density was elevated in animals with repetitively induced seizures. However, neither genetic nor pharmacological interventions had any impact on the development of generalized seizures. Other than CB1, genetic deletion or pharmacological blockade with SB366791 (1 mg/kg) of transient receptor potential vanilloid receptor 1 (TRPV1) had no effect on the duration of behavioral or electrographic seizure activity in the kindling model. In conclusion, we demonstrate that endocannabinoid, but not endovanilloid, signaling affects termination of seizure activity, without influencing seizure severity over time. These effects are dependent on the neuronal subpopulation. Thus, the data argue that the endocannabinoid system plays an active role in seizure termination but does not regulate epileptogenesis.


Asunto(s)
Epilepsia/genética , Epilepsia/patología , Excitación Neurológica/genética , Neuronas/metabolismo , Prosencéfalo/patología , Receptor Cannabinoide CB1/deficiencia , Anilidas/farmacología , Animales , Bromodesoxiuridina , Proteína Quinasa Tipo 1 Dependiente de Calcio Calmodulina/genética , Proteína Quinasa Tipo 1 Dependiente de Calcio Calmodulina/metabolismo , Antagonistas de Receptores de Cannabinoides/efectos adversos , Cinamatos/farmacología , Modelos Animales de Enfermedad , Regulación de la Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/genética , Masculino , Ratones , Ratones Noqueados , Neurogénesis/efectos de los fármacos , Neurogénesis/genética , Neuronas/efectos de los fármacos , Piperidinas/efectos adversos , Pirazoles/efectos adversos , Rimonabant , Canales Catiónicos TRPV/genética , Canales Catiónicos TRPV/metabolismo , Ácido gamma-Aminobutírico/metabolismo
3.
Rev Sci Instrum ; 84(10): 103103, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24182097

RESUMEN

The interference signal visibility V (difference to sum ratio of intensities at maximum and minimum interference) of an interferometer that uses a multimode laser is here derived for a given laser gain profile and spectral mode separation as a function of the difference Z(S) between the probe and reference beam optical path lengths and the spectral separation k(S) between the center of the laser gain profile and the nearest laser mode of higher frequency. k(S) has a significant effect on V for a given Z(S). This parameter, in lasers where it sweeps freely across the gain profile, and other effects, such as various misalignments and optical coupling inefficiencies, render V alone an unreliable parameter for quantifying Z(S) (for the purpose of reducing it, say). However, the difference to sum ratio of the maximum and minimum V due to variations in k(S) for a given Z(S) is an intrinsic property of the laser insensitive to configurational details. Parameter W so defined, therefore, proves very useful for balancing path lengths. This is of particular importance for systems where probe and/or reference beams are transmitted via long single mode optical fibers, so this application is detailed. Optical path lengths within such fibers often cannot be measured to sufficient accuracy by spatial path length measurements due to fiber nonuniformity resulting in variations in the mode's group velocity (needed to convert to optical path length). Two examples are provided using different makes and models of 0.633 µm HeNe lasers with similar specifications. In the first case, the function W(Z(S)) is calculated directly from the laser's published gain profile and mode separation. In the second case, W is determined empirically for a range of Z(S)values for a laser with an unknown gain profile in a (heterodyned) interferometer whose interference signal oscillates between maximum and minimum intensity at 80 MHz due to the reference beam's optical frequency being acousto-optically upshifted by that amount, while k(S) spontaneously varies on an acoustic time scale. A single high-bandwidth waveform record for each Z(S), therefore, provides all the information needed to determine W. Despite the second laser's gain profile apparently differing in detail, qualitative agreement is achieved between the two methods sufficient to validate the technique.

4.
Neuropathol Appl Neurobiol ; 38(5): 426-42, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21883377

RESUMEN

AIMS: Despite knowledge about the impact of brain inflammation on hippocampal neurogenesis, data on the influence of virus encephalitis on dentate granule cell neurogenesis are so far limited. Canine distemper is considered an interesting model of virus encephalitis, which can be associated with a chronic progressing disease course and can cause symptomatic seizures. METHODS: To determine the impact of canine distemper virus (CDV) infection on hippocampal neurogenesis, we compared post-mortem tissue from dogs with infection with and without seizures, from epileptic dogs with non-viral aetiology and from dogs without central nervous system diseases. RESULTS: The majority of animals with infection and with epilepsy of non-viral aetiology exhibited neuronal progenitor numbers below the age average in controls. Virus infection with and without seizures significantly decreased the mean number of neuronal progenitor cells by 43% and 76% as compared to age-matched controls. Ki-67 labelling demonstrated that hippocampal cell proliferation was neither affected by infection nor by epilepsy of non-viral aetiology. Analysis of CDV infection in cells expressing caspase-3, doublecortin or Ki-67 indicated that infection of neuronal progenitor cells is extremely rare and suggests that infection might damage non-differentiated progenitor cells, hamper neuronal differentiation and promote glial differentiation. A high inter-individual variance in the number of lectin-reactive microglial cells was evident in dogs with distemper infection. Statistical analyses did not reveal a correlation between the number of lectin-reactive microglia cells and neuronal progenitor cells. CONCLUSIONS: Our data demonstrate that virus encephalitis with and without seizures can exert detrimental effects on hippocampal neurogenesis, which might contribute to long-term consequences of the disease. The lack of a significant impact of distemper virus on Ki-67-labelled cells indicates that the infection affected neuronal differentiation and survival of newborn cells rather than hippocampal cell proliferation.


Asunto(s)
Virus del Moquillo Canino/inmunología , Moquillo/inmunología , Encefalitis Viral/patología , Hipocampo/metabolismo , Neurogénesis/fisiología , Animales , Diferenciación Celular , Proliferación Celular , Moquillo/complicaciones , Virus del Moquillo Canino/aislamiento & purificación , Perros , Encefalitis/complicaciones , Encefalitis/inmunología , Encefalitis/virología , Epilepsia/etiología , Epilepsia/inmunología , Hipocampo/inmunología , Células Madre/citología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...